From July 1, 2023 to September 30, 2023, the company has repurchased 40,000 shares, representing 2.8% for $0.19 million. With this, the company has completed the repurchase of 40,000 shares, representing 2.8% for $0.19 million under the buyback announced on June 12, 2023.
Creative Medical Technology Holdings, Inc.
Equities
CELZ
US22529Y4089
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.18 USD | -1.65% | -3.24% | -9.33% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.33% | 5.73M | |
+16.93% | 124B | |
+17.01% | 109B | |
-7.23% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-6.79% | 16.61B | |
-37.63% | 16.43B | |
+2.17% | 13.4B | |
+24.42% | 11.47B |
- Stock Market
- Equities
- CELZ Stock
- News Creative Medical Technology Holdings, Inc.
- Tranche Update on Creative Medical Technology Holdings, Inc.'s Equity Buyback Plan announced on June 12, 2023.